Viscogel AB was founded in 2008 by Dr. Mats Andersson based on his extensive research on the physiological and biological properties of chitosan. His discoveries on the relationship between the degree of deacetylation and the physiological and biological properties of chitosan led to the development and characterization of ViscosanTM, ViscoGelTM and ViscomulsionTM.

ViscoGel™ and Viscomulsion™ in contrast to other standard chitosan gels, maintain the three-dimensional structure and do not precipitate when subjected to physiological conditions. This characteristic in combination with the high drug loading capacity and controllable release properties make them suitable as drug delivery systems.